Clinical Trials Logo

Colon Cancer clinical trials

View clinical trials related to Colon Cancer.

Filter by:

NCT ID: NCT01095432 Completed - Ulcerative Colitis Clinical Trials

Partial Wave Spectroscopic Detection of Colon Cancer Risk

Brushings
Start date: March 2010
Phase: N/A
Study type: Observational

The purpose of this study is to study samples of rectal mucosa (the moist lining of the rectum) using a new light scattering technology, called partial wave spectroscopy (PWS) in patients who will undergo a standard of care colonoscopy or a flexible sigmoidoscopy and have a history of ulcerative colitis (UC).

NCT ID: NCT01092481 Active, not recruiting - Colon Cancer Clinical Trials

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Start date: January 26, 2010
Phase: Phase 3
Study type: Interventional

This study is designed to confirm that first 3 months of oxaliplatin in 6 months of modified FOLFOX-6 or CAPOX treatment is not inferior to 6 months of oxaliplatin in modified FOLFOX-6 or CAPOX treatment in terms of disease free survival in patients with stage II/III colon cancer.

NCT ID: NCT01092078 Completed - Hypertension Clinical Trials

Community-based Approaches to Treating Hypertension and Colon Cancer Prevention

MISTER-B
Start date: May 2010
Phase: N/A
Study type: Interventional

Black men constitute the demographic group with the greatest burden of premature death and disability from hypertension (HTN) in the United States. But while the disproportionately high rate of hypertension-related morbidity and mortality is well documented, the epidemic of colorectal cancer (CRC) among black men is comparatively under-appreciated. For example, CRC is a leading cause of cancer death in black men with a death rate 50% higher than in white men. Low rates of screening for CRC in this population contribute significantly to this problem. The purpose of this randomized controlled trial (RCT) is to evaluate the effect of a lifestyle intervention delivered through telephone-based motivational interviewing (MINT) versus a patient navigation intervention on blood pressure reduction and CRC screening.

NCT ID: NCT01091558 Completed - Ulcerative Colitis Clinical Trials

Study of Effects of L-Arginine in Colitis and Colon Cancer

Start date: September 2009
Phase: N/A
Study type: Observational

The purpose of this study is to look at the importance of L-Arginine in the digestive tract. L-Arginine is an amino acid and is important in making proteins within the cell. The evaluation of colon tissue, blood, urine, diet, health history, and symptoms will help us learn more about L-Arginine and ulcerative colitis. The investigators believe these studies will provide new insights into the treatment for Inflammatory Bowel Disease (ulcerative colitis) and nutritional needs. The investigators plan to enroll 200 participants in this study over the next two years.

NCT ID: NCT01071824 Recruiting - Colon Cancer Clinical Trials

Comparison of Limb Size of Transverse Coloplasty Pouch

Start date: June 2009
Phase: N/A
Study type: Interventional

The aim of the study is the comparison of pouch function with two different sizes of limb of transverse coloplasty pouch after rectal resection and total mesorectal excision.

NCT ID: NCT01068483 Completed - Breast Cancer Clinical Trials

Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients

Start date: November 2008
Phase: Phase 1
Study type: Interventional

This is a first-in-man, phase I clinical research study with BKM120, a potent and highly specific oral pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor. The study consists of a dose escalation part followed by a MTD expansion part. Once the MTD has been defined, the MTD expansion part will be opened for enrollment.

NCT ID: NCT01062919 Terminated - Colon Cancer Clinical Trials

Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery

Start date: July 2009
Phase: N/A
Study type: Interventional

This is a double blinded randomized controlled trial in patients undergoing colon open surgery. The purpose is to evaluate the effectiveness of two different analgesic techniques on functional recovery after surgery. Twenty five patients will receive thoracic epidural analgesia plus patient controlled analgesia (PCA) (epidural analgesia group) and 25 patients wound infiltration of local anesthetic plus PCA (wound infusion group). Hypothesis: the postoperative recovery of patients receiving local anesthetic wound infusion will be faster than patients receiving thoracic epidural analgesia. Functional recovery, pain intensity, opioid consumption and side effects, length of hospital stay and biological markers of inflammation after surgery will be measured in both groups.

NCT ID: NCT01048580 Completed - Colon Cancer Clinical Trials

Study of Perifosine + Capecitabine for Colon Cancer Patients

Start date: October 2009
Phase: Phase 1
Study type: Interventional

This is a Phase I study of Perifosine + Capecitabine for patients with advanced colon cancer.

NCT ID: NCT01042743 Completed - Colon Cancer Clinical Trials

Laparoscopic Surgery Versus Robot Surgery for Right-side Colon Cancer: Short-term Outcome of a Randomised Clinical Trial

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The recent introduction of robotic surgical system has revolutionized the field of minimally invasive surgery. The investigators hypothesized that adoption of a robotic surgical system for patients with right-side colon cancer seems appealing because This system provides high-definition three-dimensional vision, eliminates physiologic tremor, and better ergonomics. This randomized controlled trial was designed to determine the safety and efficacy of robotic right hemicolectomy in comparison with laparoscopic right hemicolectomy.

NCT ID: NCT01012362 Terminated - Breast Cancer Clinical Trials

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Start date: December 2009
Phase: Phase 1
Study type: Interventional

This is a Phase I study; dose escalating the combination of pazopanib when taken daily and ixabepilone when administered on day 1 of a 3 week treatment course.